Skip to Content
U.S. National Institutes of Health

If you are not registered you may register by using the following link:

New Registrations

Address questions about passwords, submissions, testing, registration to:

Mohammed Nayel
Project Manager
Contractor: NCI Chemotherapeutic Agents Repository
Fisher BioServices
Email: mohammed.nayel@nih.gov
Phone: 240-686-4720
Forgot Password?

Compound Submission Application News

UPDATED: Guidelines for Small Molecule Structures for Screening.
The Guidelines for Small Molecule Structures for Screening has been updated. Please read before submitting new structures.
IMPORTANT
There is a new non-negotiable, electronic CDA/MTA to cover future submissions that is now integrated into the submission process. Users will need to provide the name and e-mail address of a signatory from their institution who has the authority to execute the agreement. Your submission will be reviewed by DTP only after the CDA/MTA has been agreed to by your signatory. If the CDA/MTA is declined or not acted upon after 30 days, the submission request will be deleted.
Significant changes to the terms contained in the new CDA/MTA agreement.
There are significant changes to the terms contained in the new CDA/MTA agreement. To facilitate the transition, the new agreement is available for review at the following link: New NCI60 Screening CDA/MTA.
Attention IE Users
You must be using an Internet Explorer Version 7 or higher to use this application. If you encounter difficulties with the application please make sure that 'Compatibility Mode' is turned off. More information about Compatibility Mode

Registered Users Login:


*** Warning ***

You are accessing a U.S. Government information system, which includes.

  1. this computer,
  2. this computer network,
  3. all computers connected to this network, and
  4. all devices and storage media attached to this network or to a computer on this network.

This information system is provided for U.S. Government-authorized use only. Unauthorized or improper use of this system may result in disciplinary action, as well as civil and criminal penalties.

By using this information system, you understand and consent to the following: You have no reasonable expectation of privacy regarding any communications or data transiting or stored on this information system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this information system. Any communication or data transiting or stored on this information system may be disclosed or used for any lawful Government purpose.

Nothing in the preceding language overrides or modifies in any way the terms of the Discreet Screening Agreement

If you have never used our online compound submission application, you will need to register with us as an online supplier, even if you have submitted compounds to us through another method before.

Structures submitted through the compound submission application will be considered for testing in our in vitro anticancer screen. .